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Herpes simplex encephalitis (HSE) is a devastating infection of the central nervous system (CNS). Lafaille
et al. (2012) show that susceptibility to HSE is due to mutations in Toll-like receptor response pathways
that directly reduce the intrinsic resistance of neurons and other cells in the CNS to HSV infection.Herpes simplex virus type 1 (HSV-1) is
a highly evolved pathogen capable of a
benign coexistence with its human host.
Life-threatening complications are rare,
especially given its near ubiquity in adult
human populations. The high prevalence
of HSV infection is fueled in part by the
ability of the virus to establish life-long
latent infections, which are punctuated
by intermittent reactivation events (Nicoll
et al., 2012). These reactivations are
frequently asymptomatic and allow the
virus to be shed and infect other suscep-
tible individuals. The most common ex-
ceptions to this host-pathogen stalemate
are sight-threatening corneal infections
(stromal keratitis) and life-threatening
central nervous system (CNS) infections
(encephalitis). Herpes simplex encepha-
litis (HSE) predominantly affects children
and the elderly, is one of the most
common forms of viral encephalitis, and
has remarkably poor outcomes despite
the availability of good antiviral therapy
(Sabah et al., 2012). Importantly, HSE
can result from both primary infection
and reactivation of latency, and until
recently we had few clues as to why
some children seem specifically suscep-
tible to HSE. Certain inherited deficiencies
of the innate immune system have now
been shown to correlate strongly with
childhood HSE (Casrouge et al., 2006;
Herman et al., 2012; Pe´rez de Diego
et al., 2010; Zhang et al., 2007). In a recent
study, Lafaille et al. (2012) suggest that
susceptibility to HSE is caused, at least
in part, by defects in intrinsic innate
responses of the nervous system itself.
Toll-like receptor (TLR) signaling is crit-
ical for the recognition of, and response
to, a variety of pathogens. A number of
TLRs are important for resistance to HSV
in mice, but a critical aspect of theresearch of Casanova and others for
some years has been the identification
of TLR-driven pathways critical for
HSV resistance in humans. Their initial
observations were that an autosomal
recessive mutation in UNC-93B, an endo-
plasmic reticulum (ER) protein with 12
membrane-spanning domains, renders
children susceptible to HSE through
impaired interferon (IFN) responses
(Casrouge et al., 2006). UNC-93B is
essential for TLR3, TLR7, and TLR9
signaling because it is required to deliver
these TLRs from the ER to the
endosome, where they recognize patho-
gens and initiate signaling cascades that
activate immune responses (Kim et al.,
2008; Tabeta et al., 2006). While an
UNC-93B deficiency was apparently spe-
cific for resistance to HSV in humans,
UNC-93B/ mice were susceptible to a
variety of microbes. This important dif-
ference between the susceptibilities of
UNC-93B/ mice and humans serves to
highlight the importance of performing
research using human patient material.
Further strengthening the idea that UNC-
93B and its associated innate response
pathway are critical for HSE resistance is
that humans with deficiencies in down-
stream factors, such as TLR3 and the
signaling molecules TRAF3 and TBK,
phenocopy almost exactly those with
mutations in UNC-93B. While the pene-
trance of HSE in this population is incom-
plete, this previous work discovered a
very strong association between the prev-
alence of HSE and defects in the TLR3
pathway. Some key issues, however, re-
mained unresolved. For example, the
idea that UNC-93B-deficient cells were
highly susceptible to HSV infection arose
from studies using SV40-transformed
UNC-93B/ fibroblasts obtained fromCell Host & Microbe 12, Dpatients. While such data were consistent
with clinical observations, it remained
unknown whether the cells of the central
nervous system (CNS) targeted by HSV
during HSE showed a similar dependence
on TLR3-mediated IFN-driven immunity
for viral control.
Lafaille et al. (2012) in the Casanova,
Studer, and Notarangelo laboratories
therefore set about a collaborative tour
de force study in which they obtained
dermal fibroblast-derived pluripotent
stem cells and induced their differentia-
tion into neurons, oligodendrocytes, and
astrocytes (Figure 1). These three cell
types represent the primary nonhemato-
poetic cells that reside in the CNS. Exten-
sive analysis of these cells through study
of the cell-surface markers, gene-expres-
sion profiling, and electrophysiology was
required to identify and characterize
these newly derived cells. The authors
then sought to examine TLR3 responses
of these control and UNC-93B/ cells
following stimulation with poly(I:C), a
commonly used agonist of TLR3
frequently used for its mimicry of the
effects of virus-derived dsRNA. As ex-
pected, the UNC-93C-deficient CNS cells
behaved similarly to UNC-93C-deficient
fibroblasts, with significantly reduced
TLR3 pathway responses. Importantly,
these responses were restored through
provision of intact UNC-93B in trans.
The key experiments in this study, how-
ever, revealed that UNC-93C/ neurons
and oligodendrocytes were significantly
more susceptible to HSV-1 infection, as
judged by increases in green fluores-
cence when infected with a HSV-1 re-
combinant strain with GFP fused to
a structural protein (Figure 1). Interest-
ingly, the UNC-93C/ neural stem cells
(NSCs) and astrocytes did not showecember 13, 2012 ª2012 Elsevier Inc. 731
Figure 1. The Derivation of CNS Cells from Human Pluripotent Stem Cells and Their Relative
Susceptibilities to HSV-1 Infection
Induced human pluripotent stem cells (black box, center) were generated from dermal fibroblasts from
control, UNC-93B-deficient, and TLR3-deficient (not shown) subjects. These cells were then induced to
differentiate to neural precursor cells, which in turn were differentiated with growth factors to produce
neurons, oligodendrocyes, astrocytes, and neural stem cells. Infection of the differentiated CNS cells
with a GFP-expressing HSV-1 strain showed a significant increase in fluorescence in the UNC93B/
neurons and oligodendrocytes (red boxes, below) relative to wild-type controls (above). Similar results
were obtained with TLR3/ neurons and oligodendrocytes (not shown). Susceptibility of astrocytes
and neural stem cells to HSV-1 infection remained high, unchanged by their UNC-93B genotype. These
data suggest that the increased susceptibilities to HSV-1 encephalitis of humans with mutations in the
TLR3 pathway result from intrinsic changes in the susceptibilities of their resident CNS cells to HSV-1
infection. Cell and virus illustrations created by Jonathan Leib.
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although these two cell types were gener-
ally more susceptible to HSV-1 infection
than neurons and oligodendrocytes re-
gardless of genotype. One caveat to this
finding is that murine astrocytes require732 Cell Host & Microbe 12, December 13, 20TLR3 for resistance to HSV-2 (Reinert
et al., 2012), implying either that there is
a difference between humans and mice
in this regard or between astrocytes
in vitro and in vivo. While viral titers and
yields from these cells were not shown,12 ª2012 Elsevier Inc.the GFP fluorescence measurements
strongly support the conclusion that
neurons and oligodendrocytes require
an intact TLR3 pathway for resistance to
HSV. TLR3-driven innate resistance,
intrinsic to the CNS, is critical for protect-
ing the CNS, likely in addition to a require-
ment for such protective functions in
the immune system in general. When
combined with the clinical data, this
pathway appears especially important
for the protection from HSE during child-
hood. This study, and others currently
emerging, are setting the stage for a
veritable explosion of data pertaining to
the study of host-pathogen interaction in
humans, allowing confirmation or refuta-
tion of predictions based on small animal
model systems.REFERENCES
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